Question | Discussion | References | CME Credit

Case 2: References

  1. Stevenson M. HIV-1 pathogenesis. Nat Med. 2003;9:853-60.
    [The following link will open in a new window. PubMed Abstract]
  2. Greene WC, Peterlin BM. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat Med. 2002;8:673-80.
    [The following link will open in a new window. PubMed Abstract]
  3. Cooper CL, van Heeswijk RP, Gallicano K, Cameron DW. A review of low-dose ritonavir in protease inhibitor combination therapy. Clin Infect Dis. 2003;36:1585-92.
    [The following link will open in a new window. PubMed Abstract]
  4. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008;1-139. Available at:
    [The following link will open in a new window. AIDSinfo - Accessed December 15, 2008]
  5. Pommier Y, Johnson AA, Marchand C. Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov. 2005;4:236-48.
    [The following link will open in a new window. PubMed Abstract]
  6. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555-70.
    [The following link will open in a new window. PubMed Abstract]

[Back to Case 2 Question | Back to Discussion]

CME Credit | Back to Top